Signal Above Noise

December 03, 2025 Instagram

Market Summary

Daily Overview

  • On 3 December 2025, the Indian stock market showed mild negative sentiment with the Nifty 50 consolidating below the crucial 26,000 level and Sensex closing slightly down by about 31 points, reflecting short-term caution and lack of follow-through buying.
  • The market faced selling pressure for the third/fourth consecutive session, mainly due to persistent foreign institutional investor (FII) selling, although domestic institutional investors (DIIs) continued to absorb some selling by net buying.
  • Profit-booking in key private banks and financial sectors weighed on overall market indices, despite strong underlying GDP growth and expectations of a rate cut by the Reserve Bank of India later in December.
  • Broader market segments like midcaps and smallcaps experienced underperformance compared to benchmarks, with sectoral indices showing mixed performance—financials and banking pressured, while pharma showed defensive strength.
  • The Indian Rupee hitting a record low near ₹90 against the US dollar also contributed to risk-off sentiment, though early indications from GIFT Nifty around 26,200 suggested a potential gap-up start to the trading day driven by value buying and positive global cues.

Key Indices

NIFTY 50

25,986

-0.18%

SENSEX

85,106.81

-0.02%

Momentum Snapshot

IndexPrice1D1M1Y
Sensex85,106.81-0.02%1.97%5.13%
Nifty 5025,986-0.18%0.86%6.25%
Nifty Smallcap 25016,623-0.44%-4.66%-7.69%
Nifty Midcap 10060,316-0.98%0.05%4.88%
Nifty Next 5068,401-1.09%-2.95%-4.85%

Sector Highlights

IT +0.76%

The IT sector gained +0.76% driven by rupee depreciation to a fresh record low of ₹90.25 per USD. With the majority of IT sector revenues denominated in US dollars, the weakened rupee enhances earnings conversion and margins. Major gainers included Wipro (+2%), TCS (+2%), Infosys (+1%), Mphasis (+1%), and Tech Mahindra (+1%), reflecting strong investor optimism in the technology space. The Nifty IT index climbed to become one of the top sectoral gainers, with the rupee weakness stemming from persistent foreign portfolio outflows and stalled India-US trade talks.

Media +0.25%

The Media sector posted a modest gain of +0.25%, though no specific drivers or news items were identified in available market data for this sector on December 3, 2025.

Bank +0.13%

The Banking sector showed minimal movement with a +0.13% gain. However, the broader financial sector faced headwinds as the RBI Monetary Policy Committee meeting commenced on December 3, creating a cautious market sentiment. Investors adopted a wait-and-watch approach ahead of central bank policy cues on inflation, growth outlook, and interest rates, which limited upside momentum in banking stocks.

CPSE -1.22%

The CPSE sector declined -1.22% amid broader market weakness and investor caution ahead of the RBI MPC meeting. The cautious sentiment following the previous session's weak close (Sensex down 0.59%, Nifty50 down 0.55%) extended into CPSE performance, with limited sector-specific positive catalysts to offset the broader market headwinds.

PSU Bank -3.07%

The PSU Bank sector experienced a sharper decline of -3.07%, reflecting heightened caution in the banking space ahead of the RBI Monetary Policy Committee announcement. The wait-and-watch approach by investors regarding interest rate decisions and inflation outlook particularly impacted PSU banking stocks, which are sensitive to policy shifts. Additionally, the broader market weakness and previous session's decline carried over into this session.

Sector Scoreboard

Sector1D1W1Y3Y
IT +0.76% +1.94% -13.79% +20.90%
Media +0.25% +2.38% -27.68% -33.29%
Bank +0.13% +0.77% +13.75% +37.51%
CPSE -1.22% +0.10% -2.19% +123.33%
PSU Bank -3.07% +0.33% +25.21% +107.55%
Stock Spotlight Of The Day
Sun Pharma
Market Cap
4,921 Cr
Current Price
₹152
Stock P/E
Dividend Yield
0.00%
ROCE
-279%
ROE
%
Shareholding Changes (Impact Factors)
FIIs
QoQ 0.29%
YoY -0.39%
Stable foreign holding
DIIs
QoQ 0.08%
YoY 0.84%
Stable domestic holding
Promoters
QoQ 0%
YoY -0.01%
No change in promoter holding
Quarterly Summary (Absolute)
Sales
QoQ Severe drop -20%
YoY Severe drop -38.46%
Expenses
QoQ Costs rising 19.35%
YoY Sharp cut -36.21%
Operating Profit
QoQ Strong profit 26.92%
YoY Erosion -35.92%
Net Profit
QoQ Strong earnings 46.15%
YoY Collapsed -28.97%
Profit & Loss (Compounded)
Sales Growth
10 YearsNone%
5 YearsNone%
3 YearsNone%
TTM-1%
Profit Growth
10 YearsNone%
5 YearsNone%
3 YearsNone%
TTM35%
Stock Price CAGR
10 Years-8%
5 Years-5%
3 Years-16%
1 Year-30%
Return on Equity
10 YearsNone%
5 YearsNone%
3 YearsNone%
Last YearNone%
Fundamentals Corner
The company exhibits critical signs of financial distress, with consistently declining sales and significant operational losses, reflected in a deeply negative ROCE.
The stock's severe, multi-year price decline accurately mirrors this fundamental decay, and investors should exercise extreme caution as the data points to continued value erosion.
News TidBits
  • Sun Pharma has announced a major capital expenditure plan, investing ₹3,000 crore to establish a new state-of-the-art manufacturing facility in Madhya Pradesh.
  • This strategic investment is aimed at significantly expanding the company's production capacity to meet future demand, signaling strong confidence in its growth trajectory.
  • The development comes as the broader pharmaceutical sector is experiencing tailwinds from the weakening Indian Rupee, which benefits major exporters like Sun Pharma.
  • Adding to the positive sentiment around the company's ecosystem, its associate firm, Sun Pharma Advanced Research (SPARC), saw its shares surge over 30% recently following a favorable U.S. court ruling.
  • For investors, this large-scale investment underscores a long-term commitment to growth and market leadership, although such capex can impact short-term cash flows.
Tip Icon

Stacks on Stacks: Tip Time 🤑

Acknowledge that your risk tolerance is not a fixed number but an emotion that fluctuates with the market; build your portfolio for your most anxious self, not your most optimistic one.

Inside The Fund
SBI ELSS Tax Saver Fund
Fund Size: ₹ 31782.82 Cr NAV: ₹ 487.1712 (as on 02nd December, 2025)
1 Year
4.51%
Category: 3.06%
2 Year
20.81%
Category: 15.43%
3 Year
23.09%
Category: 17.28%
5 Year
23.72%
Category: 20.48%
10 Year
15.78%
Category: 15.21%
Stocks Added
StockSector1M Change
TML Commercial Vehicles Ltd.Commercial vehicles 0.66%
Stocks Removed
StockSector1M Change
Fortis Healthcare Ltd.Hospital -0.66%
Top 10 Holdings
StockHolding %1M Change
HDFC Bank Ltd. 8.88% -0.06%
Reliance Industries Ltd. 5.27% 0.21%
Tata Steel Ltd. 3.57% 0.13%
ICICI Bank Ltd. 3.14% -0.15%
Cipla Ltd. 2.88% -0.13%
ITC Limited 2.83% 0.00%
Mahindra & Mahindra Ltd. 2.76% -0.07%
State Bank Of India 2.75% 0.07%
Axis Bank Ltd. 2.51% 0.10%
Kotak Mahindra Bank Ltd. 2.41% 0.02%

The Common Ground

Shows the commonly added & removed stocks by mutual funds last month

Top Added Top Added (5)
LG Electronics India Pvt. Ltd.5 funds
Bandhan Small Cap Fund - Direct Plan - Growth0.02%
Axis Small Cap Fund - Direct Plan - Growth0.14%
HSBC Small Cap Fund - Direct Plan - Growth0.36%
Mirae Asset Small Cap Fund - Direct Plan - Growth0.05%
ITI Small Cap Fund - Direct Plan - Growth0.68%
Canara Robeco Asset Management Company Ltd.4 funds
Nippon India Small Cap Fund - Direct Plan - Growth0.23%
Axis Small Cap Fund - Direct Plan - Growth0.13%
Aditya Birla Sun Life Small cap Fund - Direct Plan - Growth0.54%
Mirae Asset Small Cap Fund - Direct Plan - Growth0.81%
Sona BLW Precision Forgings Ltd.3 funds
DSP Small Cap Fund - Direct Plan - Growth0.44%
Franklin India Small Cap Fund - Direct - Growth0.68%
ITI Small Cap Fund - Direct Plan - Growth0.87%
Canara HSBC Life Insurance Co.Ltd.3 funds
DSP Small Cap Fund - Direct Plan - Growth0.36%
ICICI Prudential Smallcap Fund - Direct Plan - Growth0.75%
Mirae Asset Small Cap Fund - Direct Plan - Growth1.35%
Paradeep Phosphates Ltd.2 funds
Bandhan Small Cap Fund - Direct Plan - Growth0.60%
ITI Small Cap Fund - Direct Plan - Growth0.93%
Top Removed Top Removed (3)
Rolex Rings Private Ltd.2 funds
Nippon India Small Cap Fund - Direct Plan - Growth-0.03%
Invesco India Smallcap Fund - Direct - Growth-0.28%
Mangalore Chemicals & Fertilisers Ltd.2 funds
Bandhan Small Cap Fund - Direct Plan - Growth-0.44%
ITI Small Cap Fund - Direct Plan - Growth-1.07%
J.b. Chemicals & Pharmaceuticals Ltd.2 funds
Invesco India Smallcap Fund - Direct - Growth-0.93%
Aditya Birla Sun Life Small cap Fund - Direct Plan - Growth-0.70%
Top News Top News Developments
Headline RBI Policy Meeting Creates Market Jitters
  • The market is in a cautious wait-and-watch mode as the RBI's Monetary Policy Committee meeting begins, leading to profit booking and a fourth straight session of losses for benchmark indices.
  • Investors are divided on whether the RBI will cut the repo rate by 25 basis points, as robust GDP growth of 8.2% complicates the decision despite record-low inflation.
  • A rate cut would be a major positive for interest-rate sensitive sectors like banking, real estate, and autos by reducing borrowing costs and boosting credit demand.
  • The RBI's decision will also be influenced by global trends, where major central banks like the US Federal Reserve are now expected to start cutting rates, creating room for a more accommodative stance.
Headline Rupee Plunges to Record Low Below 90/USD
  • The Indian Rupee breaching the psychological 90-per-dollar mark is a major headwind for the market, driving sustained FII outflows and increasing import costs.
  • This depreciation directly benefits export-oriented sectors like IT and Pharma, whose earnings in dollar terms translate to more rupees, leading to outperformance in their respective indices.
  • Conversely, sectors reliant on imports, such as oil & gas, auto components, and electronics, will face significant margin pressure due to higher input costs.
  • The currency's weakness has also fueled a rally in commodities like gold and silver, which have hit record highs as investors seek safe havens against currency devaluation.
Headline IPO Market Booms Amid Secondary Market Caution
  • E-commerce platform Meesho's ability to raise ₹2,439 crore from anchor investors ahead of its IPO highlights strong institutional demand for India's digital growth story.
  • This trend reveals a broader shift in FII strategy, where foreign investors are selling holdings in the secondary market but are eager to invest in promising companies through the primary market.
  • The success of recent IPOs like Aequs, which was oversubscribed on its first day, indicates robust retail appetite for new listings with strong fundamentals.
  • This IPO frenzy intensifies competition in sectors like e-commerce and digital retail, putting pressure on established players like Reliance Retail to innovate and retain market share.
Headline Promoter Stake Sales Signal Shifting Tides
  • A significant trend of promoter selling has emerged, with owners of major companies like IndiGo, Vedanta, and Whirlpool collectively selling stakes worth over ₹12,000 crore.
  • This activity could suggest that promoters believe their company valuations are at or near a peak, choosing to cash out or diversify their personal wealth.
  • For retail investors, heavy promoter selling can be a red flag, potentially indicating a lack of confidence in the company's near-term growth prospects.
  • This trend stands in contrast to the strong buying from DIIs, creating a dynamic where domestic funds are absorbing shares being offloaded by both FIIs and company insiders.

FII / DII Snapshot

Yesterday

FII Net: ₹-3642.30 cr

DII Net: ₹4645.94 cr

November 2025

FII Net: ₹-17500.31 cr

DII Net: ₹77083.78 cr

Daily Flows
DateFII NetDII Net
02-Dec-2025 ₹-3642.30 cr ₹4645.94 cr
01-Dec-2025 ₹-1171.31 cr ₹2558.93 cr
Monthly Flows
MonthFII NetDII Net
November 2025 ₹-17500.31 cr ₹77083.78 cr
October 2025 ₹-2346.89 cr ₹52794.02 cr
September 2025 ₹-35301.36 cr ₹65343.59 cr
August 2025 ₹-46902.92 cr ₹94828.55 cr
July 2025 ₹-47666.68 cr ₹60939.16 cr
June 2025 ₹7488.98 cr ₹72673.91 cr
• Foreign Institutional Investors (FIIs) continued their aggressive selling, offloading a net of ₹3,642.30 crore, contributing to the market's fourth consecutive day of losses.
• This selling pressure is exacerbated by the Indian Rupee's depreciation to record lows, which has prompted FIIs to pull out approximately $17 billion so far in 2025.
• In stark contrast, Domestic Institutional Investors (DIIs) acted as a stabilizing force, with robust net buying of ₹4,645.94 crore, absorbing the foreign outflows and providing crucial support to the market.
• A notable trend is emerging where FIIs are simultaneously exiting the secondary market while actively participating in the primary market, indicating a preference for new growth stories available through the ongoing IPO boom.

IPO Watchlist

Ongoing IPOs

  • The IPO market is currently very active, with three mainboard issues from Meesho, Aequs, and Vidya Wires collectively seeking to raise over ₹6,600 crore.
  • Meesho's massive ₹5,421 crore IPO has garnered significant attention after raising ₹2,439 crore from anchor investors, though it has faced some controversy regarding its anchor book allocation.
  • Aequs, an aerospace components manufacturer, is seeing strong demand with its issue being subscribed over two times on the first day, primarily driven by retail interest and positive long-term analyst ratings.
Vidya Wires  
300.01
Date: 3 Dec - 5 Dec List: 10 Dec
Subscription: 3.06x GMP: 11.54%
Aequs  
921.81
Date: 3 Dec - 5 Dec List: 10 Dec
Subscription: 3.48x GMP: 36.69%
Meesho  
5421.20
Date: 3 Dec - 5 Dec List: 10 Dec
Subscription: 2.42x GMP: 39.19%

Upcoming IPOs

  • The primary market pipeline remains strong with several issues scheduled to open soon, including Wakefit Innovations and Corona Remedies.
  • Corona Remedies, a pharma company backed by private equity firm ChrysCapital, is launching a ₹655 crore IPO and has indicated strong investor interest with a grey market premium of nearly 30%.
  • Wakefit Innovations is also set to launch its public offering, aiming to raise nearly ₹1,289 crore, reflecting continued investor appetite for new-age consumer brands.
Wakefit Innovations 1288.89
Date:8 Dec - 10 DecList:15 Dec
Subscription: - GMP: 18.46%
Corona Remedies 655.37
Date:8 Dec - 10 DecList:15 Dec
Subscription: - GMP: 29.38%
Tip Icon

Cha-Ching Cheatsheet 💵

Instead of just chasing high-growth stories, apply the 'toll booth' principle by investing in companies that own indispensable infrastructure or services, collecting steady revenue regardless of market cycles.

Global Markets

CountryIndex1D1Y3Y
🇯🇵 JapanNikkei 2251.39%29.82%80.14%
🇰🇷 South KoreaKOSPI1.02%64.07%65.81%
🇸🇬 SingaporeStraits Times0.36%21.41%39.75%
🇺🇸 USAS&P 5000.23%12.87%72.36%
🇩🇪 GermanyDAX0.15%19.12%63.43%
🇮🇳 IndiaGIFT NIFTY0.06%6.59%39.48%
🇫🇷 FranceCAC0.05%11.63%19.82%
🇮🇩 IndonesiaJakarta Composite-0.06%22.21%22.68%
🇬🇧 UKFTSE-0.19%16.49%28.16%
🇹🇭 ThailandSET Composite-0.22%-11.29%-22.34%
🇨🇳 ChinaShanghai Composite-0.51%15.28%22.87%
🇭🇰 Hong KongHang Seng-1.38%31.67%37.83%
  • The US Federal Reserve ended its Quantitative Tightening program, injecting $13.5 billion liquidity back into financial markets, aiding improved global liquidity conditions.
  • Global commodity prices showed signs of stabilization with hopes of stimulus measures in China supporting metal prices, indirectly benefiting related sectors in India.
  • The US economy registered upward growth revisions, bolstering global risk appetite, though cautious investor sentiment prevailed due to possible US political developments including GOP tax plans.
  • Global equity markets showed cautious optimism, with mixed performances across regions; Asian markets hinted at positive momentum while Europe was relatively flat amid geopolitical concerns.
  • The Indian Rupee's weakness against the US dollar was partly influenced by the strengthening US dollar globally and renewed safe-haven demand amidst intermittent geopolitical tensions.

Emerging Opportunities

The financial services sector, despite near-term weakness, offers medium- to long-term opportunities owing to upcoming RBI rate cuts expected to spur lending growth and credit demand.
Defensive sectors like pharmaceuticals are attracting investor interest due to their resilience and stable earnings profile amid broader market volatility.
Technology-enabled companies, including those involved in AI acquisitions (e.g., Tata Communications’ recent acquisition of an AI firm stake), present promising growth prospects leveraging digital transformation.
The metal sector may benefit from global commodity price stabilization and China's stimulus efforts, making selective metal stocks attractive for cyclical recovery plays.
Contrarian investments in large-cap stocks experiencing profit-booking or foreign outflows but supported by strong domestic demand and institutional buying, such as some private banks and consumer goods companies, could yield medium-term gains.

Policy & Regulations

  • SEBI is reportedly considering new eligibility criteria for derivatives trading, potentially linking access to the Futures and Options (F&O) segment to an investor's existing equity portfolio size.
  • This move could significantly impact retail participation in the F&O market by introducing stricter entry barriers, aiming to curb speculative activity.
  • In a separate development, the government has decided against increasing the Foreign Direct Investment (FDI) limit in public sector banks, which led to a sharp fall in the Nifty PSU Bank index as it dampened investor hopes for capital infusion and reforms.
  • The RBI also reaffirmed the status of SBI, HDFC Bank, and ICICI Bank as Domestic Systemically Important Banks (D-SIBs), mandating them to maintain higher capital buffers to ensure financial stability, which reinforces their systemic importance but also increases their capital requirements.

Crypto Buzz

NamePriceMarket Cap24h ChangeATH Change
Bitcoin (BTC) $92984 $1.85T 6.41%-26.34%
Ethereum (ETH) $3066.25 $369.56B 8.42%-38.10%
Tether (USDT) $1 $184.71B 0.01%-24.41%
XRP (XRP) $2.17 $131.02B 7.08%-40.46%
BNB (BNB) $896.88 $123.49B 6.38%-34.59%
  • The cryptocurrency market experienced a significant surge, with Bitcoin rising over 6% to trade above $92,000 and Ethereum jumping more than 8% to cross the $3,000 mark.
  • This broad-based rally was fueled by renewed institutional interest, leading to the liquidation of approximately $400 million in bearish positions across major tokens.
  • The sharp upward movement has pushed the total cryptocurrency market capitalization higher by over 7%, indicating a strong positive shift in investor sentiment.